https://www.selleckchem.com/pr....oducts/dabrafenib-gs
se reduction/avoidance of polypharmacy should not be recommended to minimise side-effects.Parkinson's disease (PD) decreases the quality of life of the affected individuals. The incidence of PD is expected to increase given the growing aging population. Motor symptoms associated with PD render the patients unable to self-care and function properly. Given that several drugs have been developed to control motor symptoms, highly sensitive scales for clinical evaluation of drug efficacy are needed. Among such scales, the objec
Like
Comment
Share
